Scalper1 News
Shares of biotechs moved lower in afternoon trading Wednesday — along with the broader markets — even though Amgen (AMGN) topped quarterly earnings and revenue views after Tuesday’s close and analysts expect strong results from Biogen Idec (BIIB) and Celgene (CELG) when they report on Thursday. Wednesday’s dip comes during an otherwise robust recent run for IBD’s Medical-Biomed/Biotech group, which ranks No. 1 out of 197 industries tracked. The Scalper1 News
Scalper1 News